117 related articles for article (PubMed ID: 15899703)
21. Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4.
Melo PMS; El Chamy Maluf S; Azevedo MF; Paschoalin T; Budu A; Bagnaresi P; Henrique-Silva F; Soares-Costa A; Gazarini ML; Carmona AK
Parasitol Int; 2018 Apr; 67(2):233-236. PubMed ID: 29288140
[TBL] [Abstract][Full Text] [Related]
22. Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.
Subramanian S; Hardt M; Choe Y; Niles RK; Johansen EB; Legac J; Gut J; Kerr ID; Craik CS; Rosenthal PJ
PLoS One; 2009; 4(4):e5156. PubMed ID: 19357776
[TBL] [Abstract][Full Text] [Related]
23. Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development.
Hanspal M; Dua M; Takakuwa Y; Chishti AH; Mizuno A
Blood; 2002 Aug; 100(3):1048-54. PubMed ID: 12130521
[TBL] [Abstract][Full Text] [Related]
24. Cysteine protease falcipain 1 in Plasmodium falciparum is biochemically distinct from its isozymes.
Goh SL; Goh LL; Sim TS
Parasitol Res; 2005 Oct; 97(4):295-301. PubMed ID: 16041608
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones.
Shenai BR; Lee BJ; Alvarez-Hernandez A; Chong PY; Emal CD; Neitz RJ; Roush WR; Rosenthal PJ
Antimicrob Agents Chemother; 2003 Jan; 47(1):154-60. PubMed ID: 12499184
[TBL] [Abstract][Full Text] [Related]
26. Probing the structure of falcipain-3, a cysteine protease from Plasmodium falciparum: comparative protein modeling and docking studies.
Sabnis YA; Desai PV; Rosenthal PJ; Avery MA
Protein Sci; 2003 Mar; 12(3):501-9. PubMed ID: 12592020
[TBL] [Abstract][Full Text] [Related]
27. Distinct and stage specific nuclear factors regulate the expression of falcipains, Plasmodium falciparum cysteine proteases.
Sunil S; Chauhan VS; Malhotra P
BMC Mol Biol; 2008 May; 9():47. PubMed ID: 18477411
[TBL] [Abstract][Full Text] [Related]
28. Differences in biochemical properties of the Plasmodial falcipain-2 and berghepain-2 orthologues: implications for in vivo screens of inhibitors.
Chan C; Goh LL; Sim TS
FEMS Microbiol Lett; 2005 Aug; 249(2):315-21. PubMed ID: 16019160
[TBL] [Abstract][Full Text] [Related]
29. Falcipain-1, a Plasmodium falciparum cysteine protease with vaccine potential.
Kumar A; Kumar K; Korde R; Puri SK; Malhotra P; Singh Chauhan V
Infect Immun; 2007 Apr; 75(4):2026-34. PubMed ID: 17242063
[TBL] [Abstract][Full Text] [Related]
30. Characterization of native falcipain, an enzyme involved in Plasmodium falciparum hemoglobin degradation.
Francis SE; Gluzman IY; Oksman A; Banerjee D; Goldberg DE
Mol Biochem Parasitol; 1996 Dec; 83(2):189-200. PubMed ID: 9027752
[TBL] [Abstract][Full Text] [Related]
31. Folding of the Plasmodium falciparum cysteine protease falcipain-2 is mediated by a chaperone-like peptide and not the prodomain.
Sijwali PS; Shenai BR; Rosenthal PJ
J Biol Chem; 2002 Apr; 277(17):14910-5. PubMed ID: 11827964
[TBL] [Abstract][Full Text] [Related]
32. Falcipain inhibition as a promising antimalarial target.
Marco M; Coterón JM
Curr Top Med Chem; 2012; 12(5):408-44. PubMed ID: 22242849
[TBL] [Abstract][Full Text] [Related]
33. Blocking Plasmodium falciparum development via dual inhibition of hemoglobin degradation and the ubiquitin proteasome system by MG132.
Prasad R; Atul ; Kolla VK; Legac J; Singhal N; Navale R; Rosenthal PJ; Sijwali PS
PLoS One; 2013; 8(9):e73530. PubMed ID: 24023882
[TBL] [Abstract][Full Text] [Related]
34. Falcipain cysteine proteases of malaria parasites: An update.
Rosenthal PJ
Biochim Biophys Acta Proteins Proteom; 2020 Mar; 1868(3):140362. PubMed ID: 31927030
[TBL] [Abstract][Full Text] [Related]
35. Plasmodium food vacuole plasmepsins are activated by falcipains.
Drew ME; Banerjee R; Uffman EW; Gilbertson S; Rosenthal PJ; Goldberg DE
J Biol Chem; 2008 May; 283(19):12870-6. PubMed ID: 18308731
[TBL] [Abstract][Full Text] [Related]
36. Antiplasmodial activity of extracts from seven medicinal plants used in malaria treatment in Cameroon.
Boyom FF; Kemgne EM; Tepongning R; Ngouana V; Mbacham WF; Tsamo E; Zollo PH; Gut J; Rosenthal PJ
J Ethnopharmacol; 2009 Jun; 123(3):483-8. PubMed ID: 19442463
[TBL] [Abstract][Full Text] [Related]
37. Double-stranded RNA-mediated gene silencing of cysteine proteases (falcipain-1 and -2) of Plasmodium falciparum.
Malhotra P; Dasaradhi PV; Kumar A; Mohmmed A; Agrawal N; Bhatnagar RK; Chauhan VS
Mol Microbiol; 2002 Sep; 45(5):1245-54. PubMed ID: 12207693
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues.
Biot C; Pradines B; Sergeant MH; Gut J; Rosenthal PJ; Chibale K
Bioorg Med Chem Lett; 2007 Dec; 17(23):6434-8. PubMed ID: 17949976
[TBL] [Abstract][Full Text] [Related]
39. Cloning and sequence characterisation of falcipain-2 from Plasmodium falciparum Gombak A strain (Malaysia).
Sim TS; Loke P; Lee MA; Singh M; Flotow H
Parasitol Res; 2001 Sep; 87(9):683-6. PubMed ID: 11570549
[TBL] [Abstract][Full Text] [Related]
40. Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase.
Salas F; Fichmann J; Lee GK; Scott MD; Rosenthal PJ
Infect Immun; 1995 Jun; 63(6):2120-5. PubMed ID: 7768590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
